Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank40
3Y CAGR-5.3%
5Y CAGR-27.3%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-5.3%/yr
Annual compound
5Y CAGR
-27.3%/yr
Recent acceleration
Percentile
P40
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 63.19 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 74.32 | -74.9% |
| 2020 | 296.19 | -5.0% |
| 2019 | 311.64 | - |